Clinical Trial: A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07404553) titled 'A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors' on Feb. 05.

Brief Summary: The purpose of the study is to evaluate the efficacy and safety of SHR-1918 in patients with hypercholesterolemia with inadequate lipid control on statins plus PCSK9 inhibitors. The efficacy and safety of SHR-1918 will be evaluated after 12-weeks and 24-weeks treatment.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Hypercholesterolemia

Intervention: DRUG: SHR-1918 Injection

SHR-1918 injection.

DRUG: SHR-1918 Injection Placebo

SHR-1918 injection placebo...